ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Consumer Staples / RDGT / insiders
YI (37) PETS (19) GRDN (71) CVS (60) ⌘ Pro Terminal →

Ridgetech Inc. (RDGT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$0.81 +0.88% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.81

Ridgetech Inc. (RDGT) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $2.9M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on RDGT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $0.81 (+0.88% 1D, market cap $2.9M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, RDGT ranks #114 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does RDGT compare to YI and PETS in the Consumer Staples sector?
▼

Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, YI (111 Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $25.1M) and PETS (PetMed Express Inc.) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.8M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for RDGT?
▼

Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.81 (-0.03%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510036
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Cash (10)Whales (6)SEC (8)Macro (7)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-9.9% Base Target
$799 Bull$1 Base$1 Bear
📬 FREE RDGT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RDGT)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (36/100 Composite)
🔍 WHY RDGT SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+10/20 pts (28% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 3.6% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
44
Grade D$0.86-3.5% Next Q
Q2 (-2Q)
41
Grade D$0.83+9.6% Next Q
Q3 (-1Q)
39
Grade E$0.91-11% Next Q
Current
36
Grade D-$0.81-8.3% Hist 90D α
Trajectory: D (44) → D- (36)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a RDGT Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While RDGT currently carries a cautious 36/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Staples with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.88) and Max Pain ($0.85) forces dealer call-delta covering toward $798.52.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $RDGT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “RDGT Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
YES 36%NO 64%Trade / Inspect Odds →
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

RDGT Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (RDGT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on RDGT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RDGT)

  • ✓Walkthrough of RDGT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
RDGT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -46.00%⚡ TESTING RESISTANCE
2026-11-03O $0.83H $0.83L $0.80C $0.81VOL 15.4K
RES: $0.98SUP: $0.80SMA50: $0.88SMA200: $64.23
$291.0$212.3$133.6$54.95$-23.75RES $0.98SUP $0.80$0.812026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

RDGT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 RDGT Butterfly Map → + Track RDGT →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +10.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on RDGT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for RDGT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for RDGT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RDGT)

Consumer Staples Rank #114 of 146 ⚔️ YI vs RDGT Full Matrix →

1. Head-to-Head Consumer Staples Peer Comparison (RDGT vs. YI, PETS, GRDN, CVS)

Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)

Across 146 tracked Consumer Staples securities in the Roarable RQD universe, Ridgetech Inc. (RDGT) ranks #114 by composite RQD confidence (36/100, grade D-) and #140 by equity capitalization ($2.9M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with RDGT at 36/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
RDGT ACTIVE
Ridgetech Inc.
D- 36/100 — 3.6% — +0.88% $2.9M Benchmark Subject
YI
111 Inc.
D- 37/100 — 5.8% -20.5% +2.46% $25.1M /yi-vs-rdgt →
PETS
PetMed Express Inc.
E 19/100 — 28.1% -35.0% +0.84% $25.8M /pets-vs-rdgt →
GRDN
Guardian Pharmacy Services Inc. (Class A)
B- 71/100 52.1x 20.2% 37.7% -1.70% $2.58B /grdn-vs-rdgt →
CVS
CVS Health Corporation
C- 60/100 65.3x 45.0% 2.6% -1.93% $115.43B /cvs-vs-rdgt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001856084

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Ridgetech Inc. (RDGT) reported GAAP revenue of $132.2M (+10.2% vs. FY2024 revenue of $120.0M , and +6.6% cumulative change since FY2023) , GAAP net income of -$1.3M, operating cash flow of -$1.4M, and free cash flow of -$1.4M (-227.6% YoY). On the balance sheet, RDGT closed FY2025 with $61.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-31 $132.2M -$1.3M -$1.4M -$1.4M $61.4M —
FY2024 (FY) 2025-03-31 $120.0M $10.2M $1.2M $1.1M — —
FY2023 (FY) 2024-03-31 $124.0M -$4.2M -$3.2M -$3.2M — —

3. RDGT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $0.81 (+0.88% 1D, market cap $2.9M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, RDGT ranks #114 in composite RQD confidence.

How does RDGT compare to YI and PETS in the Consumer Staples sector?

Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, YI (111 Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $25.1M) and PETS (PetMed Express Inc.) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.8M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for RDGT?

Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is RDGT trading relative to its 50-day, 200-day, and 52-week technical levels?

RDGT last traded at $0.81 (+0.88% on volume of 13,762 shares), positioning the stock -7.95% below its 50-day simple moving average ($0.88) and -98.74% below its 200-day simple moving average ($64.23). Across its 52-week range of $0.67 to $760.50, RDGT sits at the 0.0% percentile with a 14-day RSI of 44.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.91).

Direct Sub-Reports: RDGT RQD Cockpit RDGT 12M Forecast RDGT Earnings & Move RDGT Dividends & DRIP RDGT Insiders & 13F RDGT Whale Options RDGT Profit Sankey RDGT News & Why
ROARABLE RATING BRIEF • RQD 36/100 (D-) ✓ SEC XBRL & RQD VERIFIED

RDGT — Ridgetech Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Ridgetech Inc. (RDGT) earns a live Roarable RQD composite score of 36/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $0.81 (+0.88% 1D, market capitalization $2.9M).

  • Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of —, gross margin of 3.6%, operating margin of -1.4%, and free cash flow yield of —.
  • Whale 13F & Options Flow (6/20) + Insider Conviction (8/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (7/20) + Forensic Balance Sheet (5/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Ridgetech Inc. Is a NASDAQ-listed issuer classified in the Consumer Staples sector, within the Retail-Drug Stores and Proprietary Stores industry..0B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Ridgetech Inc. (RDGT) reported $132.2M in annual revenue (up from $120.0M in FY2024, +10.2% YoY) and -$1.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($124.0M revenue, -$4.2M net income) through FY2025, RDGT scaled operating cash flow to -$1.4M and free cash flow to -$1.4M, backed by $61.4M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 36/100): Established market leader in Consumer Staples with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 6/20. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $0.67 – $760.50 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -1.4% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Retail-Drug Stores and Proprietary Stores (Consumer Staples), RDGT carries a macro regime beta of 1.00 and gross margin of 3.6%.

  • Key Question #1: Can RDGT sustain or expand its -1.4% operating margin and — ROIC against Retail-Drug Stores and Proprietary Stores peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $132.2M and free cash flow of -$1.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is RDGT's equity valuation to Consumer Staples capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

RDGT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Ridgetech Inc. (RDGT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to RDGT Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

RDGT Bull vs. Bear Conversation Board — What's Your Call at $0.81?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON RDGT 🐻 33% BEARISH CONVICTION
1. Pick Your Side on RDGT:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $0.93 (+16.3%)
📌 Pinned Debate

Price action shows documented upside moves, including a 2.82% gain to $0.87 and a 15.45% post-earnings share climb despite an EPS miss.

Picked up a starter position in RDGT in my $100K Virtual Cash book at $0.80. Price action shows documented upside moves, including a 2.82% gain to $0.87 and a 15.45% post-earnings share climb despite an EPS miss.. Trading inside a $0.67–$760.50 52-week range with 0.0% FCF yield gives solid downside support if Retail-Drug Stores and Proprietary Stores multiples expand this quarter.

VolSurface_Trader 🐂 BULL

@SkepticalCFA Shorting a 6/20 institutional whale-flow stock at $0.80 is dangerous when funds are rotating into Consumer Staples.

SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH 🎯 Target: $0.63 (-21.3%)
Spot @ $0.80

The RQD rating scores the forensic balance sheet at 8/20 with Piotroski F at 1/9, while ROIC and FCF yield are both 0%.

Here is the bear case nobody on the bull side wants to address on RDGT: The RQD rating scores the forensic balance sheet at 8/20 with Piotroski F at 1/9, while ROIC and FCF yield are both 0%.. At current EV/EBITDA multiples, even a small guidance miss in Retail-Drug Stores and Proprietary Stores triggers a 12-15% air pocket.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%